Hormonal injection approved for treatment of hypoparathyroidism
The FDA recently approved a parathyroid hormone product, Natpara (NPS Pharmaceuticals), to control hypocalcaemia in patients with hypoparathyroidism. Healio
Source: Society for Endocrinology - Category: Endocrinology Source Type: news